Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Liquid Embolics Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Isobutyl-2-Cyanoacrylate(IBCA)
  • 1.3.3 Ethanol
  • 1.3.4 Sodium Morrhuate
  • 1.3.5 Bletilla Striata
  • 1.3.6 Others
• 1.4 Market Segment by Application
  • 1.4.1 Global Liquid Embolics Market Share by Application (2019-2025)
  • 1.4.2 Tumor and Brain Cancer
  • 1.4.3 Brain Arteriovenous Malformations
  • 1.4.4 Ischemic Stroke
  • 1.4.5 Brain Aneurysm
  • 1.4.6 Others
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Liquid Embolics Market Size
  • 2.1.1 Global Liquid Embolics Revenue 2014-2025
  • 2.1.2 Global Liquid Embolics Sales 2014-2025
• 2.2 Liquid Embolics Growth Rate by Regions
  • 2.2.1 Global Liquid Embolics Sales by Regions 2014-2019
  • 2.2.2 Global Liquid Embolics Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Liquid Embolics Sales by Manufacturers
  • 3.1.1 Liquid Embolics Sales by Manufacturers 2014-2019
  • 3.1.2 Liquid Embolics Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Liquid Embolics Revenue by Manufacturers (2014-2019)
  • 3.2.2 Liquid Embolics Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Liquid Embolics Market Concentration Ratio (CR5 and HHI)
• 3.3 Liquid Embolics Price by Manufacturers
• 3.4 Key Manufacturers Liquid Embolics Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Liquid Embolics Market
• 3.6 Key Manufacturers Liquid Embolics Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Isobutyl-2-Cyanoacrylate(IBCA) Sales and Revenue (2014-2019)
  • 4.1.2 Ethanol Sales and Revenue (2014-2019)
  • 4.1.3 Sodium Morrhuate Sales and Revenue (2014-2019)
  • 4.1.4 Bletilla Striata Sales and Revenue (2014-2019)
  • 4.1.5 Others Sales and Revenue (2014-2019)
• 4.2 Global Liquid Embolics Sales Market Share by Type
• 4.3 Global Liquid Embolics Revenue Market Share by Type
• 4.4 Liquid Embolics Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Liquid Embolics Sales by Application

6 United States

• 6.1 United States Liquid Embolics Breakdown Data by Company
• 6.2 United States Liquid Embolics Breakdown Data by Type
• 6.3 United States Liquid Embolics Breakdown Data by Application

7 European Union

• 7.1 European Union Liquid Embolics Breakdown Data by Company
• 7.2 European Union Liquid Embolics Breakdown Data by Type
• 7.3 European Union Liquid Embolics Breakdown Data by Application

8 China

• 8.1 China Liquid Embolics Breakdown Data by Company
• 8.2 China Liquid Embolics Breakdown Data by Type
• 8.3 China Liquid Embolics Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Liquid Embolics Breakdown Data by Company
• 9.2 Rest of World Liquid Embolics Breakdown Data by Type
• 9.3 Rest of World Liquid Embolics Breakdown Data by Application
• 9.4 Rest of World Liquid Embolics Breakdown Data by Countries
  • 9.4.1 Rest of World Liquid Embolics Sales by Countries
  • 9.4.2 Rest of World Liquid Embolics Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Medtronic
  • 10.1.1 Medtronic Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Liquid Embolics
  • 10.1.4 Liquid Embolics Product Introduction
  • 10.1.5 Medtronic Recent Development
• 10.2 Boston Scientific
  • 10.2.1 Boston Scientific Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Liquid Embolics
  • 10.2.4 Liquid Embolics Product Introduction
  • 10.2.5 Boston Scientific Recent Development
• 10.3 St. Jude Medical
  • 10.3.1 St. Jude Medical Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Liquid Embolics
  • 10.3.4 Liquid Embolics Product Introduction
  • 10.3.5 St. Jude Medical Recent Development
• 10.4 Cyberonics
  • 10.4.1 Cyberonics Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Liquid Embolics
  • 10.4.4 Liquid Embolics Product Introduction
  • 10.4.5 Cyberonics Recent Development
• 10.5 Codman & Shurtleff
  • 10.5.1 Codman & Shurtleff Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Liquid Embolics
  • 10.5.4 Liquid Embolics Product Introduction
  • 10.5.5 Codman & Shurtleff Recent Development
• 10.6 Stryker
  • 10.6.1 Stryker Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Liquid Embolics
  • 10.6.4 Liquid Embolics Product Introduction
  • 10.6.5 Stryker Recent Development
• 10.7 Integra LifeSciences
  • 10.7.1 Integra LifeSciences Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Liquid Embolics
  • 10.7.4 Liquid Embolics Product Introduction
  • 10.7.5 Integra LifeSciences Recent Development
• 10.8 InoMed
  • 10.8.1 InoMed Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Liquid Embolics
  • 10.8.4 Liquid Embolics Product Introduction
  • 10.8.5 InoMed Recent Development
• 10.9 Mizuho America
  • 10.9.1 Mizuho America Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Liquid Embolics
  • 10.9.4 Liquid Embolics Product Introduction
  • 10.9.5 Mizuho America Recent Development
• 10.10 RauMedic
  • 10.10.1 RauMedic Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Liquid Embolics
  • 10.10.4 Liquid Embolics Product Introduction
  • 10.10.5 RauMedic Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Liquid Embolics Sales Channels
  • 11.2.2 Liquid Embolics Distributors
• 11.3 Liquid Embolics Customers

12 Market Forecast

• 12.1 Global Liquid Embolics Sales and Revenue Forecast 2019-2025
• 12.2 Global Liquid Embolics Sales Forecast by Type
• 12.3 Global Liquid Embolics Sales Forecast by Application
• 12.4 Liquid Embolics Forecast by Regions
  • 12.4.1 Global Liquid Embolics Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Liquid Embolics Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

In 2019, the market size of Liquid Embolics is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Liquid Embolics.

This report studies the global market size of Liquid Embolics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Liquid Embolics sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Medtronic
Boston Scientific
St. Jude Medical
Cyberonics
Codman & Shurtleff
Stryker
Integra LifeSciences
InoMed
Mizuho America
RauMedic

Market Segment by Product Type
Isobutyl-2-Cyanoacrylate(IBCA)
Ethanol
Sodium Morrhuate
Bletilla Striata
Others

Market Segment by Application
Tumor and Brain Cancer
Brain Arteriovenous Malformations
Ischemic Stroke
Brain Aneurysm
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Liquid Embolics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Liquid Embolics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Liquid Embolics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025